SK Chemical and MSD Korea in strategic alliance for vaccines.

Published: 2007-04-11 06:57:00

Updated: 2007-04-11 06:57:00

SK Chemical announced on April 9 that the company made a strategic alliance with MSD Korea for the distribution of Gardasil, a first cervical cancer vaccine and Rotateq, an anti-rotavirus vaccine.

According to the agreement SK will be responsible for those vaccines to make order, distribute an...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK